Publications

Publications

1. Patterson WB, Craven DE, Schwartz DA, Nardell EA, Kasmer J, Noble J.  Occupational hazards to hospital personnel.  Ann Intern Med 1985;  102:658-80.

2. Nardell E, McInnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. New Engl J Med 1986; 315:1570-5.

3. Riley RL, Nardell EA. Clearing the air – the theory and application of ultraviolet air disinfection. Am Rev Resp Dis 1989; 139:1286-94.

4. Nardell EA.  Tuberculosis in homeless, residential care facilities, prisons, nursing homes, and other close communities.  Semin Respir Infect 1989;  4:206-15.

5. Nardell EA.  Dodging droplet nuclei. Reducing the probability of nosocomial tuberculosis transmission in the AIDS era.  Am Rev Respir Dis 1990;  142:501-3.

6. Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne Infection: the theoretical limits of protection achievable by building ventilation. Am Rev Resp Dis 1991; 144:302-6.

7. Fennelly K, Nardell E. The relative efficacy of respirators and room ventilation in preventing occupational tuberculosis. Infection Control Hosp Epidemiol 1998; 10:754-9.

8. Ko G, Burge HA, Nardell EA, Thompson KM. Estimation of tuberculosis risk and incidence under upper room ultraviolet germicidal irradiation in a waiting room in a hypothetical scenario. Risk Anal 2001; 21(4):657-73.

9. Brickner PW, Vincent RL, First M, Nardell E, Murray M, Kaufman W.  The application of ultraviolet germicidal irradiation to control transmission of airborne disease: bioterrorism countermeasure. Public Health Rep 2003;118(2):99-114.

10. Nardell EA. Environmental infection control of tuberculosis.  Semin Respir Infect 2003;  18:307-19.

11. Ko G, Thompson KM, Nardell EA. Estimation of tuberculosis risk on a commercial airliner. Risk Anal 2004; 24(2):379-88.

12. Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G.  Inhaling to mitigate exhaled bioaerosols.  Proc Natl Acad Sci U S A 2004;101(50):17383-8.

13. First MW, Weker RA, Yasui S, Nardell EA.  Monitoring human exposures to upper-room germicidal ultraviolet irradiation.  J Occup Environ Hyg. 2005 May 2 (5): 285-92.

14. Hohmuth BA, Yamanija JC, Dayal AS, Nardell E, Salazar JJ, Smith Fawzi MC.  Latent tuberculosis infection: risks to health care students at a hospital in Lima, Peru.  Int J Tuberc Lung Dis 2006;  10:1146-51.

15. Friedland G, Churchyard GJ, Nardell E.  Tuberculosis and HIV coinfection: current state of knowledge and research priorities.  J Infect Dis 2007;  196 Suppl 1:S1-3.

16. Bock NN, Jensen PA, Miller B, Nardell E.  Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment.  J Infect Dis 2007;  196 Suppl 1:S108-13.

17. Safety of upper-room ultraviolet germicidal air disinfection for room occupants: results from the Tuberculosis Ultraviolet Shelter Study. Nardell EA, Bucher SJ, Brickner PW, Wang C, Vincent RL, Becan-McBride K, James MA, Michael M, Wright JD. Public Health Rep. 2008 Jan-Feb;123(1):52-60.

18. Dharmadhikari AS, Nardell EA.  What animal models teach humans about tuberculosis.  Am J Respir Cell Mol Biol 2008;  39:503-8.

19. Radonovich LJ, Martinello RA, Hodgson M, Milton DK, Nardell EA.  Influenza and ultraviolet germicidal irradiation.  Virol J 2008;  5:149

20. Javaheri S, Nardell EA, Kazemi H. Role of PCO2 as determinant of CSF (HCO3) in metabolic acidosis. Resp Physiol 1979; 36:155-66.

21. Javaheri S, Nardell EA. Severe metabolic alkalosis. Br Med J 1981; 283:1016-7.

22. Nardell EA, Brody JS. Determinants of the mechanical properties of rat lung during postnatal development. J Appl Physiol 1981; 53(1):140-8.

23. Singleton L, Turner M, Haskal R, Etkind S, Tricarico M, Nardell E. Long-term hospitalization for tuberculosis control. Experience with a medical-psychosocial inpatient unit. JAMA 1997:278(10): 838-42.

24.  Subramanyan GS,Yokoe DS, Sharnprapai S, Nardell E, McCray E, Platt R. Using automated pharmacy records to assess the management of tuberculosis. Emerg Infect Dis 1999;5(6):788-91.

25. Yokoe DS, Subramanyan GS, Nardell E, Sharnprapai S, McCray E, Platt R. Supplementing tuberculosis surveillance with automated data from health maintenance organizations. Emerg Infect Dis 1999;5(6):779-87.

26. Sharprappai S, Miller AC, Suruki R, Corkren E, Etkind S, Driscoll J, McGerry M, Nardell E. Genotyping analysis of tuberculosis Cases in the U.S.- and foreign-born Massachusetts residents. Emerg Infect Dis [serial online] 2002:8. Available from: URL: http://www.cdc.gov/ncidod/EID/vol8no11/02-0370.htm

27. Northrup JM, Miller AC, Nardell E, Sharnprapai S, Etkind S, Driscoll J, et al. Estimated costs of false laboratory diagnoses of tuberculosis in three patients. Emerg Infect Dis [serial online] 2002;8. Available from: URL: http://www.cdc.gov/ncidod/EID/vol8no11/02-0387.htm

28. Szot A, Jacobson F, Munn S, Jazayeri D, Nardell E, Harrison D, Drosten R, Ohno-Machado L, Smeaton LM, Fraser HSF. Diagnostic accuracy of chest X-rays acquired using a digital camera for low-cost teleradiology. Int. J. Med. Inform., 2004; 73(1): 65-73.

29. Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC.  Drug resistance profiles of Mycobacterium tuberculosis isolates: five years’ experience and insight into treatment strategies for MDR-TB in Lima, Peru. Int J Tuberc Lung Dis 2005; 9:175-80.

30. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Int J Tuberc Lung Dis. 2006 Mar;10(3):290-6.

31. Nardell EA, Wallis RS.  Here today–gone tomorrow: the case for transient acute tuberculosis infection.  Am J Respir Crit Care Med 2006;  174:734-5.

32. Nardell EA, Mitnick CD.  Are second-line drugs necessary to control multidrug-resistant tuberculosis?  J Infect Dis 2006;  194:1194-6.

33. Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM, Shin D, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E.  Infect Control Hosp Epidemiol. 2008 Sep;29(9):878-86.

34. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, et al.   Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.  Lancet 2008;  372:1403-9.

35. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, et al.   Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.  Ann N Y Acad Sci 2008;  1136:1-11.

36. Pollock NR, Kashino SS, Napolitano DR, Sloutsky A, Joshi S, Guillet J, et al.   Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results.  Infect Control Hosp Epidemiol 2009;  30:392-5.